ORCID Profile
0000-0002-9777-4373
Current Organisations
King's College London
,
UFRB
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: SAGE Publications
Date: 24-03-2021
Publisher: Wiley
Date: 31-07-2021
DOI: 10.1111/JGS.17387
Abstract: Robust quality indicators (QIs) are essential for monitoring and improving the quality of care and learning from good practice. We aimed to identify and assess QIs for the care of older people and people with dementia who are nearing the end of life and recommend QIs for use with routinely collected electronic data across care settings. A systematic review was conducted, including five databases and reference chaining. Studies describing the development of QIs for care of older people and those with dementia nearing the end of life were included. QIs were categorized as relating to processes or outcomes, and mapped against six care domains. The psychometric properties (acceptability, evidence base, definition, feasibility, reliability, and validity) of each QI were assessed QIs were categorized as robust, moderate, or poor. From 12,980 titles and abstracts screened, 37 papers and 976 QIs were included. Process and outcome QIs accounted for 780 (79.7%) and 196 (20.3%) of all QIs, respectively. Many of the QIs concerned physical aspects of care (n = 492, 50.4%), and very few concerned spiritual and cultural aspects of care (n = 19, 1.9%). Three hundred and fifteen (32.3%) QIs were robust and of those 220 were measurable using routinely collected electronic data. The final shortlist of 71 QIs came from seven studies. Of the numerous QIs developed for care of older adults and those with dementia nearing the end of life, most had poor or moderate psychometric properties or were not designed for use with routinely collected electronic datasets. Infrastructure for data availability, combined with use of robust QIs, is important for enhancing understanding of care provided to this population, identifying unmet needs, and improving service provision.
Publisher: European Respiratory Society (ERS)
Date: 12-09-2020
Publisher: FapUNIFESP (SciELO)
Date: 12-2018
DOI: 10.1590/1983-21252018V31N413RC
Abstract: ABSTRACT The objective of the present study was to evaluate the tolerance to cadmium (Cd) of sunflower genotypes grown in greenhouse conditions, and the effectiveness of using photosynthetic parameters as physiological indicators of this tolerance. Seeds of two sunflower genotypes previously identified as tolerant (H358) and Cd-sensitive (AG960) to Cd were used. The seeds were germinated in plastic cups containing plant substrate after 9 days, the seedlings were transplanted to plastic basins containing a nutrient solution with 0 or 10 µM of Cd, where they remained for 16 days. S les of the plants were harvested every 5 days. The experiment was carried out in a randomized complete design, using a 4×2×2 factorial arrangement (4 days of grown in a nutrient solution with Cd, 2 sunflower genotypes, and 2 Cd levels) with four replications. Cd stress decreased CO2 net assimilation, stomatal conductance, carboxylation efficiency, photosynthetic pigment contents, potential quantum yield (Fv/Fm), and effective quantum yield of plants of the two evaluated genotypes. The decrease in photosynthetic rates of these plants was caused by both stomatal and non-stomatal limitations. Plants of the AG960 genotype showed more pronounced deleterious effects due to Cd stress than those of the H358 genotype. Thus, CO2 net assimilation rate, stomatal conductance, and chloroplast pigment content are good physiological indicators of sunflower tolerance to Cd and can at least in part, explain the greater tolerance of the H358 genotype to Cd stress when compared to the AG960 genotype.
Publisher: Elsevier BV
Date: 07-2019
Publisher: Wiley
Date: 15-01-2020
DOI: 10.1002/GPS.5251
Abstract: Globally, the number of people with dementia who have palliative care needs will increase fourfold over the next 40 years. The Empowering Better End-of-Life Dementia Care (EMBED-Care) Programme aims to deliver a step change in care through a large sequential study, spanning multiple work streams. We will use mixed methods across settings where people with dementia live and die: their own homes, care homes, and hospitals. Beginning with policy syntheses and reviews of interventions, we will develop a conceptual framework and underpinning theory of change. We will use linked data sets to explore current service use, care transitions, and inequalities and predict future need for end-of-life dementia care. Longitudinal cohort studies of people with dementia (including young onset and prion dementias) and their carers will describe care transitions, quality of life, symptoms, formal and informal care provision, and costs. Data will be synthesised, underpinned by the Knowledge-to-Action Implementation Framework, to design a novel complex intervention to support assessment, decision making, and communication between patients, carers, and inter-professional teams. This will be feasibility and pilot tested in UK settings. Patient and public involvement and engagement, innovative work with artists, policymakers, and third sector organisations are embedded to drive impact. We will build research capacity and develop an international network for excellence in dementia palliative care. EMBED-Care will help us understand current and future need, develop novel cost-effective care innovations, build research capacity, and promote international collaborations in research and practice to ensure people live and die well with dementia.
Publisher: Royal College of Physicians
Date: 03-2021
Location: United Kingdom of Great Britain and Northern Ireland
Location: United Kingdom of Great Britain and Northern Ireland
Location: United Kingdom of Great Britain and Northern Ireland
Location: United Kingdom of Great Britain and Northern Ireland
No related grants have been discovered for Katherine Sleeman.